TSS
CYCN icon

Two Sigma Securities’s Cyclerion Therapeutics CYCN Stock Holding History

Two Sigma Securities’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,012
Closed -$17K – 2695
2022
Q3 		$17K Sell
1,012
-1,720
-63% -$29.6K ﹤0.01% 2317
2022
Q2 		$30K Buy
+2,732
New +$39.1K ﹤0.01% 1903

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Securities's CYCN Position: Q4 2022 in Review

Two Sigma Securities sold out of Cyclerion Therapeutics (CYCN) in Q4 2022, closing a stake of 1,012 shares — an estimated $17K sold.

Two Sigma Securities first reported a position in CYCN in Q2 2022 and held it in 2 quarters. The position peaked at $30K in Q2 2022. 40 funds tracked by Wall St. Rank hold CYCN as of Q4 2022.

  • Two Sigma Securities reported no remaining Cyclerion Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 1,012 Cyclerion Therapeutics shares in Q4 2022, an estimated $17K.
  • Two Sigma Securities first reported a position in Cyclerion Therapeutics in Q2 2022 and held it in 2 quarters.
  • Two Sigma Securities's Cyclerion Therapeutics position peaked at $30K in Q2 2022.
  • 40 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.